The interactions of hexafluorenium with depolarizing and competitive neuromuscular blocking agents.
D000818:Animals; D003650:Decamethonium Compounds / Q000037:antagonists & inhibitors / Q000494:pharmacology / Q000633:toxicity; D003964:Diaphragm / Q000187:drug effects; D004347:Drug Interactions; D004357:Drug Synergism; D004558:Electric Stimulation; D005260:Female; D005449:Fluorenes / Q000008:administration & dosage / Q000494:pharmacology* / Q000633:toxicity; D066298:In Vitro Techniques; D007928:Lethal Dose 50; D008297:Male; D051379:Mice; D009119:Muscle Contraction / Q000187:drug effects; D009132:Muscles / Q000187:drug effects; D009467:Neuromuscular Depolarizing Agents / Q000008:administration & dosage / Q000494:pharmacology* / Q000633:toxicity; D003473:Neuromuscular Nondepolarizing Agents / Q000008:administration & dosage / Q000494:pharmacology* / Q000633:toxicity; D000644:Quaternary Ammonium Compounds / Q000008:administration & dosage / Q000494:pharmacology* / Q000633:toxicity; D011817:Rabbits; D051381:Rats; D013045:Species Specificity; D013390:Succinylcholine / Q000008:administration & dosage / Q000494:pharmacology / Q000633:toxicity; D014403:Tubocurarine / Q000008:administration & dosage / Q000037:antagonists & inhibitors / Q000494:pharmacology / Q000633:toxicity
D003650:Decamethonium Compounds; D005449:Fluorenes; D009467:Neuromuscular Depolarizing Agents; D003473:Neuromuscular Nondepolarizing Agents; D000644:Quaternary Ammonium Compounds; D013390:Succinylcholine; D014403:Tubocurarine